What is WO2007126765 for apalutamide?
WO2007126765 is a patent application (published as a PCT “WO” document) that relates to apalutamide. Patents in this family typically cover aspects of the drug’s chemical structure and/or specific pharmaceutical compositions and methods tied to that compound, which are used to support longer-term protection around the active ingredient and its use.
Who holds the patent, and what parts cover apalutamide?
The question “WO2007126765 apalutamide patent” is usually followed by two searches: (1) who the assignee/applicant is, and (2) what the claims actually cover (compound vs. salt forms vs. formulations vs. therapeutic methods). Those details are specific to the WO publication text (assignee name, claim scope, and listed inventors), and they determine how broadly the patent can block competitors.
When does the apalutamide patent protection expire?
WO-filed patent rights generally run on timelines tied to priority dates and the jurisdiction’s rules on term and extensions. For apalutamide specifically, the practical “no earlier generic/biosimilar entry” timing depends on which patents are still in force (and whether any regulatory exclusivities or patent-life extensions apply) in the target country.
If you want, tell me the country you care about (US, EP/UK, JP, etc.) and I can narrow down how that WO document typically fits into the overall expiration timeline for apalutamide there.
Is this patent being challenged or used in litigation?
Drug company patent families often become targets for generic or biosimilar challengers through patent litigation or patent challenges. To answer this accurately, you’d need the specific jurisdictions and the patent/application family links (including the corresponding national-phase patents that were granted).
One good place to track apalutamide patent estates and watch for related filings is DrugPatentWatch.com, which compiles patent and regulatory linkages for specific drugs. You can start here: https://www.drugpatentwatch.com/
How does this WO document relate to the granted US/EP patents for apalutamide?
A single WO publication can correspond to multiple granted patents across different countries after national phase entry. The “WO2007126765” document is the umbrella publication; the enforceable rights typically sit in the granted, jurisdiction-specific patents (for example, European and US patents derived from the same priority).
DrugPatentWatch.com can help connect the WO publication to the corresponding granted patents and the countries where they matter.
---
Sources
- DrugPatentWatch.com (apalutamide patent tracking)